相似文献
1
Polypharmacy in older adults with HIV infection: Effects on the brain.
J Am Geriatr Soc. 2022 Mar;70(3):924-927. doi: 10.1111/jgs.17569. Epub 2021 Dec 1.
2
Polypharmacy in the HIV-infected older adult population.
Clin Interv Aging. 2013;8:749-63. doi: 10.2147/CIA.S37738. Epub 2013 Jun 21.
3
[The HIV population is aging].
Ugeskr Laeger. 2013 Nov 18;175(47):2870-3.
4
HIV in older adults.
Geriatrics. 2008 Dec;63(12):6-12.
5
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0.
6
Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016.
PLoS One. 2018 Sep 11;13(9):e0203890. doi: 10.1371/journal.pone.0203890. eCollection 2018.
7
Addressing Polypharmacy in Older Adults Living With HIV.
J Assoc Nurses AIDS Care. 2019 Jan-Feb;30(1):73-79. doi: 10.1097/JNC.0000000000000028.
8
Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.
Clin Interv Aging. 2016 Aug 26;11:1149-57. doi: 10.2147/CIA.S108072. eCollection 2016.
9
Short Communication: Getting Older with HIV: Increasing Frequency of Comorbidities and Polypharmacy in Brazilian HIV Patients.
AIDS Res Hum Retroviruses. 2019 Nov/Dec;35(11-12):1103-1105. doi: 10.1089/AID.2019.0069. Epub 2019 Sep 30.
10
Comorbidities in Older Persons with Controlled HIV Infection: Correlations with Frailty Index Subtypes.
AIDS Patient Care STDS. 2020 Jul;34(7):284-294. doi: 10.1089/apc.2020.0051.
引用本文的文献
1
Executive Functioning Training for Reducing Cognitive Intra-Individual Variability in People Living with HIV: A Pilot Randomized, Controlled Trial Protocol.
Nursing (Auckl). 2025;15:17-28. doi: 10.2147/nrr.s492990. Epub 2025 Feb 17.
2
Use of Nonrecommended Antivirals Among Medicare Beneficiaries With HIV.
JAMA Netw Open. 2025 May 1;8(5):e258296. doi: 10.1001/jamanetworkopen.2025.8296.
3
Predicting Neurobehavioral Outcomes in People with HIV.
Res Sq. 2025 Mar 27:rs.3.rs-5618870. doi: 10.21203/rs.3.rs-5618870/v1.
本文引用的文献
1
Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV.
AIDS. 2021 Mar 1;35(3):381-391. doi: 10.1097/QAD.0000000000002768.
2
A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV.
J Antimicrob Chemother. 2020 Dec 1;75(12):3425-3432. doi: 10.1093/jac/dkaa329.
3
Deprescribing of non-antiretroviral therapy in HIV-infected patients.
Eur J Clin Pharmacol. 2020 Mar;76(3):305-318. doi: 10.1007/s00228-019-02785-z. Epub 2019 Dec 21.
4
Polypharmacy in HIV: recent insights and future directions.
Curr Opin HIV AIDS. 2020 Mar;15(2):126-133. doi: 10.1097/COH.0000000000000608.
5
Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study.
J Int AIDS Soc. 2019 Jun;22(6):e25297. doi: 10.1002/jia2.25297.
6
Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis.
AIDS Patient Care STDS. 2019 Mar;33(3):93-103. doi: 10.1089/apc.2018.0190.
7
Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
Antivir Ther. 2019;24(3):193-201. doi: 10.3851/IMP3293.
8
Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016.
PLoS One. 2018 Sep 11;13(9):e0203890. doi: 10.1371/journal.pone.0203890. eCollection 2018.
9
Polypharmacy among HIV positive older adults on anti-retroviral therapy attending an urban clinic in Uganda.
BMC Geriatr. 2018 May 29;18(1):125. doi: 10.1186/s12877-018-0817-0.
10
Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women.
J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):83-91. doi: 10.1097/QAI.0000000000001755.
Zotero 插件